The meta-analysis demonstrated that urinary CCL14 has a good overall accuracy in predicting persistent AKI, with an overall discriminatory accuracy of 0.84 (0.80–0.87) (Additional file 1: Fig. S8). This evidence concerns the gene CCL14 and acute kidney injury.